Coexisting depressive symptoms do not limit the benefits of chronic neuromodulation: A study of over 200 patients

Aims To examine the relationship between coexisting depressive symptoms and outcomes after staged neuromodulation procedures for refractory urological symptoms. Methods Adults who enrolled in a prospective database and completed a Personal Health Questionnaire Depression Scale (PHQ‐8) at baseline we...

Full description

Saved in:
Bibliographic Details
Published in:Neurourology and urodynamics 2018-02, Vol.37 (2), p.815-822
Main Authors: Killinger, Kim A., Fergus, Jonathan, Edwards, Luke, Boura, Judith A., Bartley, Jamie, Gupta, Priyanka, Tomakowsky, Janice, Gilleran, Jason, Peters, Kenneth M.
Format: Article
Language:English
Subjects:
depressive symptoms
implantable neurostimulators
overactive
urinary bladder
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims To examine the relationship between coexisting depressive symptoms and outcomes after staged neuromodulation procedures for refractory urological symptoms. Methods Adults who enrolled in a prospective database and completed a Personal Health Questionnaire Depression Scale (PHQ‐8) at baseline were reviewed. The PHQ‐8 and Generalized Anxiety Disorder (GAD‐7) assessed depressive/anxiety symptoms pre and 6 months post device implant. Urological symptoms were assessed with The Interstitial Cystitis Symptom Index/Problem Index (ICSI‐PI) and Overactive Bladder Questionnaire (OAB‐q) at baseline, 3 and 6 months, and Global Response Assessments (GRA) post implant. Subjects, grouped by PHQ 
ISSN:0733-2467
1520-6777
DOI:10.1002/nau.23356